Mereo BioPharma Group plc (MAH0) - Total Liabilities

Latest as of September 2025: €7.00 Million EUR ≈ $8.19 Million USD

Based on the latest financial reports, Mereo BioPharma Group plc (MAH0) has total liabilities worth €7.00 Million EUR (≈ $8.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MAH0 cash flow metrics to assess how effectively this company generates cash.

Mereo BioPharma Group plc - Total Liabilities Trend (2016–2024)

This chart illustrates how Mereo BioPharma Group plc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Mereo BioPharma Group plc to evaluate the company's liquid asset resilience ratio.

Mereo BioPharma Group plc Competitors by Total Liabilities

The table below lists competitors of Mereo BioPharma Group plc ranked by their total liabilities.

Company	Country	Total Liabilities
Manomay Tex India Limited NSE:MANOMAY	India	Rs4.91 Billion
S H L Telemedicine Ltd SW:SHLTN	Switzerland	CHF38.98 Million
JP Morgan Global Growth & Income PLC LSE:JGGI	UK	GBX151.54 Million
MoneyHero Limited Class A Ordinary Shares NASDAQ:MNY	USA	$37.48 Million
Jeil Technos Co.Ltd KQ:038010	Korea	₩36.98 Billion
Beammwave AB B ST:BEAMMW-B	Sweden	Skr6.25 Million
Sumi Indo Kabel Tbk JK:IKBI	Indonesia	Rp25.31 Million
Lohakit Metal Public Company Limited BK:LHK	Thailand	฿425.43 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Mereo BioPharma Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MAH0 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mereo BioPharma Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mereo BioPharma Group plc (2016–2024)

The table below shows the annual total liabilities of Mereo BioPharma Group plc from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€15.42 Million ≈ $18.03 Million	-3.39%
2023-12-31	€15.96 Million ≈ $18.66 Million	-39.10%
2022-12-31	€26.21 Million ≈ $30.64 Million	-31.77%
2021-12-31	€38.41 Million ≈ $44.91 Million	-50.70%
2020-12-31	€77.92 Million ≈ $91.09 Million	+68.68%
2019-12-31	€46.19 Million ≈ $54.00 Million	+33.87%
2018-12-31	€34.51 Million ≈ $40.34 Million	+1.93%
2017-12-31	€33.85 Million ≈ $39.58 Million	+350.87%
2016-12-31	€7.51 Million ≈ $8.78 Million	--

About Mereo BioPharma Group plc

F:MAH0 Germany Biotechnology

Market Cap

$40.19 Million

€34.37 Million EUR

Market Cap Rank

#22669 Global

#1995 in Germany

Share Price

€0.22

Change (1 day)

-6.09%

52-Week Range

€0.22 - €2.45

All Time High

€4.48